Leerink upgraded Doximity (DOCS) to Outperform from Market Perform with a price target of $90, up from $60. While “admittedly late on this,” ...
Canaccord raised the firm’s price target on Doximity (DOCS) to $71 from $60 and keeps a Hold rating on the shares. The firm noted they reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback